Solid state sensor for touch-based fast physiological and chemical sensing

Through tightly spaced or interleaved electrode design, non-invasive sensing is solved by using natural sweat, and the problem of hydrogel dependence is achieved, painless, maintenance-free, highly accurate glucose monitoring is achieved, simplifying operation and improving equipment availability.

CN119072270APending Publication Date: 2024-12-03RGT UNIV OF CALIFORNIA
View PDF 0 Cites 6 Cited by

Patent Information

Application Number
CN202380024845.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-01-06
Filing Date
2023-01-06
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing rapid touch-based physiological and chemosensing technologies rely on hydrogels, have dilution and accumulation problems, and are inconvenient to operate, making it difficult to achieve efficient and repeatable physiological and chemosensing.

Method used

Using tightly spaced or interlaced electrode design, non-invasive sensing is performed through natural sweat at fingertips, eliminating dependence on hydrogels, and electrochemical reactions are achieved using functional electrode materials such as PEDOT:PSS and glucose oxidase. Fast and accurate glucose monitoring.

Benefits of technology

Achieving painless, maintenance-free, frequently reusable glucose monitoring, providing high accuracy and high reproducibility of blood glucose data, low average absolute relative difference (MARD) of 8.69%, with commercial finger-punching and continuous glucose monitors Quite , simplifying the sensing process and improving the usability of the device.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119072270A_ABST
    Figure CN119072270A_ABST
Patent Text Reader

Abstract

Methods, materials, and devices related to solid state gel-free sensors for touch-based rapid physiological and chemical sensing are disclosed. In some embodiments of the disclosed technology, a sensor device includes a substrate, a plurality of first electrodes and a plurality of second electrodes formed on the substrate, a first current collector formed on the substrate and connected to the plurality of first electrodes at an end of each first electrode, and a second current collector formed on the substrate and connected to the plurality of second electrodes at an end of each second electrode. And a second current collector formed on the substrate and connected to the plurality of second electrodes at one end of each of the second electrodes, in which the first electrodes and the second electrodes are alternately arranged, and adjacent first and second electrodes are spaced apart from each other by a predetermined distance.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This patent document claims priority to and the benefit of U.S. Provisional Application No. 63 / 266,513, filed on January 6, 2022, entitled “Gel-free Sensor for Touch-based Rapid Physiological and Chemical Sensing”. The entire contents of the foregoing patent application are incorporated by reference as part of the disclosure of this document. Technical Field

[0002] The disclosed technology relates to methods and apparatus regarding solid-state sensors for rapid touch-based physiological and chemical sensing. background

[0003] Recent fingertip touch-based sensors enable the collection of sweat from the fingertips without the need for motion or active extraction using hygroscopic porous hydrogels to collect analytes and electrolytes covering the electrode surface for rapid non-invasive sensing. However, such sensors still require the use of hydrogels that are prone to drying and present additional problems during sensing due to analyte dilution and accumulation. The use of hydrogels is also difficult in its implementation and storage, making the device and operation less practical and less easy for the user. Overview

[0004] The disclosed technology can be implemented in some embodiments to provide methods, materials, and devices for solid-state, gel-free sensors for touch-based rapid physiological and chemical sensing.

[0005] In some embodiments of the disclosed technology, the sensor device includes a substrate, a plurality of first electrodes formed on the substrate and extending in a first direction, a plurality of second electrodes formed on the substrate and extending in the first direction, a first current collector formed on the substrate and connected to the plurality of first electrodes at one end of each first electrode, and a second current collector formed on the substrate and connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes and the second electrodes are alternately arranged in a second direction, and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0006] In some embodiments of the disclosed technology, the sensor device includes a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each first electrode; and a second current collector formed on a substrate and connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes and the second electrodes are arranged alternately, and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0007] In some embodiments of the disclosed technology, the sensor device includes a plurality of electrode arrays for simultaneously or sequentially sensing a plurality of biomarkers of physiological parameters, wherein each electrode array includes: a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each first electrode; and a second current collector formed on a substrate and connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes are alternately arranged with the second electrodes, and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0008] In some embodiments of the disclosed technology, a sensor array includes a plurality of sensor devices, wherein the plurality of sensor devices are formed on a substrate for simultaneously or sequentially sensing a plurality of biomarkers in a biological fluid from different locations of the body.

[0009] In some embodiments, the method includes placing the sensor device in contact with the skin of the subject, and using the sensor device to measure biomarkers in a biological fluid from the skin of the subject. In some embodiments, the sensor device may include a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each first electrode; and a second current collector connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes and the second electrodes are alternately arranged, and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0010] The above and other aspects and embodiments of the disclosed technology are described in more detail in the drawings, the description and the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Figures 1A to 1C An example of a sensor comprising at least two electrodes implemented based on some embodiments of the disclosed technology is shown. Figure 1D A fingertip is shown in contact with a sensor implemented based on some embodiments of the disclosed technology. Figure 1E Examples of solid-state gel-free sensors for touch-based rapid physiological and chemical sensing implemented based on some embodiments of the disclosed technology are shown. Figure 1F Radially aligned interdigitated electrodes are shown, as implemented in accordance with some embodiments of the disclosed technology. Figure 1G Interleaved electrodes implemented according to some embodiments of the disclosed technology are shown. Figure 1H Concentrically interlaced electrodes implemented according to some embodiments of the disclosed technology are shown. Fig. 1I Shown are multiplexed arrays of sensors for detecting multiple biomarkers based on some embodiments of the disclosed technology. Figure 1J and Figure 1KMultiplexed electrodes for detecting multiple biomarkers and physiological signals on the same sensor are shown. Figure 1L Examples of spacing between electrodes are shown.

[0012] Figure 2A An example of an electrode functionalized with glucose oxidase is shown. Figure 2B An example of an electrode functionalized with lactate oxidase is shown. Figure 2C An example of an electrode functionalized with alcohol oxidase is shown.

[0013] FIG. 3A to FIG. 3F Solid-state interdigitated electrodes (IDEs) for rapid glucose sensing using natural fingertip sweat are shown.

[0014] FIG. 4A to FIG. 4G The design and use optimization of a solid-state, gel-free, touch-based IDE sensor is shown.

[0015] FIG. 5A to FIG. 5D Calibration and extended on-body evaluation of a solid-state, gel-free, touch-based glucose sensor are shown.

[0016] Figure 6 Shown is a staining experiment that visualizes the distribution of sweat along the fingertips over time.

[0017] Fig. 7A and Figure 7B In vitro characterization of the IDE sensor is shown.

[0018] Fig. 8A and Figure 8B In vitro calibration of the IDE glucose sensor is shown.

[0019] Fig. 9 The selectivity of the IDE glucose sensor was demonstrated.

[0020] Fig. 10A and Fig. 10B Optimization of the inter-electrode spacing is shown.

[0021] Fig.11A and Fig. 11B Sensor reproducibility characterization is shown.

[0022] FIG. 12A to FIG. 12D Correlations of touch-based glucose levels with fingerstick capillary blood glucose (CBG) during 3-h and 12-h extended glucose monitoring trials are shown.

[0023] Fig.13A and Fig. 13B Clarke Error Grid Analysis (CEGA) with additional calibration and time delay correction is shown.

[0024] Fig.14 Example methods for measuring biomarkers in biological fluids based on some embodiments of the disclosed technology are shown. Details

[0025] Methods, materials and devices for solid-state gel-free sensors for touch-based rapid physiological and chemical sensing are disclosed. The disclosed technology can be implemented in some embodiments to provide new non-invasive, painless sensors for direct sampling and frequent measurement of biomarkers and related physiological states (e.g., sweat rate) in sweat. The sensor can operate with direct contact with the user using a fingertip or any other skin surface that emits passive, natural, thermoregulated exocrine sweat and measures the concentration of various ions and biomolecules (e.g., sodium, potassium, chloride, glucose, lactate, urea, uric acid, bilirubin, hydroxybutyric acid, vitamins, alcohol, levodopa, caffeine, cortisol, insulin, explosives, anesthetics, nerve agents, fluoride, calcium, zinc, lead, cadmium, mercury) in sweat via electrical (e.g., conductivity, piezoresistance, thermal resistance, piezoelectric capacitance, thermoelectric, piezoelectric), chemical (e.g., nonspecific adsorption, specific binding, intercalation, insertion) or electrochemical (e.g., catalysis, redox reaction) transduction methods. The sensor uses a closely spaced or interlaced electrode design that ensures a small inter-electrode distance (<1 mm), which enables ion pathways between two or more electrodes to be used for signal transduction when in contact with a fingertip. Some embodiments of the disclosed technology can avoid the need for external analyte collection mechanisms, such as using hydrogels, hydrocolloids, porous materials, microfluidic channels, microneedles, iontophoresis, reverse iontophoresis, transdermal cholinergic delivery, etc., and allow for fast, maintenance-free user-friendly near real-time biochemical and physiological sensing via direct skin contact. Therefore, the device also allows for reusability and extended operating time, allowing the user to repeatedly and frequently use the same sensor after simple cleaning (wiping with a tissue or rinsing with water).

[0026] Diabetics who need continuous glucose monitoring use highly invasive and painful finger-pricking blood glucose meters. Developed optional continuous glucose monitoring systems, but still need to insert a needle into the body for continuous sensing, which is invasive and requires maintenance. In order to sense glucose and many other biomarkers important to human health, new wearable sensors are proposed, characterized by non-invasive sensing from more easily accessible biological fluids (such as sweat or interstitial fluid). The use of such epidermal sensors usually requires a difficult analyte extraction process (such as exercise, heating or iontophoresis), and relies on complex device structures (such as microfluidic devices, microneedles, iontophoresis patches, etc.). Such a process is invasive, complex, and the maintenance cost of self-monitoring is very high. In addition, these devices require a large amount of analyte, or require a special analyte absorption mechanism (such as microfluidic channels or hydrogels) to ensure coverage of the electrode surface.

[0027] Recently, fingertip touch-based sensors have been proposed that are able to collect sweat from the fingertips for rapid non-invasive sensing without the need for motion or active extraction using hygroscopic porous hydrogels to collect analytes and electrolytes covering the electrode surface, and have been demonstrated for sensing a variety of chemicals. However, this approach still requires the use of hydrogels that are prone to drying and presents additional problems during sensing due to analyte dilution and accumulation. The use of hydrogels is also difficult in its implementation and storage, making the device and operation less practical and less easy for the user.

[0028] The disclosed technology can be implemented in some embodiments to provide a new method for epidermal sweat sensing that avoids the need for any laborious sweat collection process, such as motion, heating, chemical stimulation, or iontophoretic extraction. By using closely spaced electrodes functionalized with transducers for biomarkers, users can sense non-invasively, painlessly, and maintenance-free in a rapid manner. The closely spaced or interleaved electrode design avoids the use of hydrogels, which makes the device more accessible, simple, stable, and useful for frequent repeated measurements.

[0029] Figures 1A to 1C An example of a sensor is shown that includes at least two electrodes implemented based on some embodiments of the disclosed technology. Figure 1D A fingertip is shown in contact with a sensor implemented based on some embodiments of the disclosed technology. Figure 1E An example of a gel-free sensor for touch-based rapid physiological and chemical sensing implemented based on some embodiments of the disclosed technology is shown. Figure 1F Radially aligned staggered electrodes are shown, as implemented in accordance with some embodiments of the disclosed technology. Figure 1GInterleaved electrodes implemented according to some embodiments of the disclosed technology are shown. Figure 1H Concentrically interlaced electrodes implemented according to some embodiments of the disclosed technology are shown. Fig. 1I Shown are multiplexed arrays of sensors for detecting multiple biomarkers based on some embodiments of the disclosed technology. Figure 1J and Figure 1K Multiplexed electrodes for detecting multiple biomarkers and physiological signals on the same sensor are shown. Figure 1L Examples of spacing between electrodes are shown.

[0030] In some embodiments of the disclosed technology, the sensor device includes a plurality of first electrodes extending in a first direction, a plurality of second electrodes extending in the first direction, a first current collector connected to the plurality of first electrodes at one end of each first electrode, and a second current collector connected to the plurality of second electrodes at one end of each second electrode.

[0031] In some embodiments of the disclosed technology, the first electrode and the second electrode are arranged very close to each other (for example, the distance between adjacent first electrodes and second electrodes may be less than 1 mm). Figure 1A As shown, in one example, the first electrode and the second electrode and the first current collector and the second current collector are arranged in the same direction. Figure 1C As shown, in another example, the first electrode and the second electrode and the first current collector and the second current collector are arranged in different directions. Figure 1B As shown, the first electrode has a certain shape, and the second electrode has a shape that at least partially surrounds the first electrode.

[0032] refer to Figure 1E In some embodiments, the first electrode can be a working electrode and the second electrode can be a reference / counter electrode.

[0033] refer to Figure 1F to Figure 1H , the first electrode (e.g., working electrode) and the second electrode (e.g., reference / counter electrode) are arranged alternately, and adjacent first electrodes and second electrodes are spaced a predetermined distance apart from each other. In some embodiments, the distance between adjacent first electrodes and second electrodes can be about 1 mm. In one example, the distance between adjacent first electrodes and second electrodes is less than 1 mm. In another example, Figure 1L As shown, the distance between adjacent first electrodes and second electrodes is greater than 1 mm.

[0034] In one embodiment, if Figure 1F As shown, the first electrode (e.g., working electrode) and the second electrode (e.g., reference / counter electrode) are interlaced with each other and arranged radially. In another embodiment, as Figure 1GAs shown, the first electrode (e.g., working electrode) and the second electrode (e.g., reference / counter electrode) are interlaced and arranged in parallel with each other. In another embodiment, as Figure 1H As shown, a first electrode (eg, a working electrode) and a second electrode (eg, a reference / counter electrode) are concentrically arranged.

[0035] refer to Figure 1F to Figure 1H , forming a current collector, then forming a reference / counter electrode on the current collector, and forming a working electrode on the reference / counter electrode. In some embodiments, an insulator is formed on the working electrode, a signal transduction layer is formed on the insulator, and a protective layer is formed on the signal transduction layer.

[0036] In some embodiments, the sensor device includes a plurality of electrode arrays, each electrode array including a first electrode and a second electrode as discussed in this patent document. Fig. 1I As shown, different electrode arrays 142 , 144 , 146 can be used to detect different biomarkers: biomarker 1 , biomarker 2 , biomarker 3 .

[0037] In some embodiments, Figure 1J and Figure 1K As shown, the first electrode may include a first working electrode WE-1 and a second working electrode WE-2. Figure 1J and Figure 1K As shown, the sensor device can further include a reference electrode. In some embodiments, as Figure 1J and Figure 1K As shown, the sensor device may further comprise additional sensors for measuring resistance and / or temperature.

[0038] Figure 2A An example of an electrode functionalized with glucose is shown. Figure 2B An example of an electrode functionalized with lactate is shown. Figure 2C An example of an electrode functionalized with an alcohol is shown.

[0039] The device is a sensor consisting of at least two electrodes, wherein at least two electrodes are in a closely spaced or interdigitated configuration with a minimum distance of <1 mm. The sensor comprises a substrate made of glass, silicon, paper, textile, or polymeric plastic or elastomer. The electrodes can be fabricated via thin film deposition processes (e.g., inkjet printing, sputtering, chemical / physical vapor deposition), thick film deposition processes (e.g., screen printing, spraying, flexographic printing), hydraulic or other additive or subtractive manufacturing processes (e.g., computer numerical control milling, laser ablation, 3D printing, electrospinning). The sensor should include a conductive electrode, which can be composed of: metal (e.g., Cu, Ag, Au, Pt), doped metal oxide (e.g., ITO, FTO), carbonaceous material (e.g., graphite, graphene, reduced graphene oxide, activated carbon, carbon nanotubes, diamond), conductive polymer (e.g., PEDOT:PSS, polypyrrole, polyaniline, polyparaphenylene, polythiophene), or 2D material (e.g., MoS2, WSe2, VO2). Electrodes can be functionalized with various chemical / electrochemical transducers for sensing biomarkers, such as enzymes (e.g., lactate oxidase, lactate dehydrogenase, glucose oxidase, glucose dehydrogenase, bilirubin oxidase, uricase, urea oxidase, alcohol oxidase, alcohol dehydrogenase, tyrosinase, catalase), catalysts (e.g., platinum, ruthenium, palladium, rhodium, silver), redox mediators (Prussian blue, Meldola's blue, methylene blue, indigo carmine, 2,2'-bipyridine, 1,4-naphthoquinone, tetrathiafulvalene, tetracyanoquinodimethane, ferrocene), antibodies, ion selective membranes, silver / silver chloride mixtures, molecularly imprinted membranes, or aptamers. Sensors can include additional closely spaced electrodes or interdigitated electrodes for physiological sensing, as well as physical transducers (e.g., thermal resistance, thermoelectric, piezoresistive, piezoelectric capacitance, piezoelectric, photovoltaic, physisorption, or chemisorption materials) that sense physical properties (e.g., temperature, skin moisture level, or pressure). The sensor may also include a protective layer composed of a polymeric material (e.g., Nafion, chitosan, ethyl cellulose, polyvinyl chloride). The sensor may also include an insulating layer composed of a dielectric material. The electrode layer composition may be a single material listed above, or a mixture or composite of the above materials.

[0040] The fabricated sensor can be used for non-invasive chemical sensing with optional complementary physiological sensing. In one example, a user can use closely spaced or interlaced sensors functionalized with glucose oxidase for quick and simple sensing of glucose in sweat in order to establish a correlation with blood glucose levels. The user can directly press the sensor for about 30s to 60s, where a chronoamperometric signal will be read to obtain a signal when a potential step is applied. In another example, a user can use closely spaced or interlaced sensors made of poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) and lactate oxidase, and closely spaced or interlaced sensors made of silver to simultaneously sense sweat lactate levels and skin moisture levels, and the skin moisture data can be used to calibrate the sweat lactate signal. In another example, a user can use closely spaced or interlaced 3-electrode sensors, where one of the electrodes is functionalized with a pH-sensitive polyaniline polymer, and the other electrode is functionalized with an alcohol oxidase. The user can press directly on the sensor for 30s to 60s, with a potential step of a chronoamperometry applied to the enzyme electrode, the open circuit potential monitored on the pH sensitive electrode, and sweat pH data and sweat alcohol signal obtained simultaneously, and the sweat alcohol signal is calibrated using the sweat pH data to improve accuracy. In these examples, the sensor can be simply reused multiple times after quickly and simply cleaning the electrode surface by rinsing with water or wiping with a paper towel. In order to perform nearly real-time measurements over an extended period of time, other measurement methods (e.g., blood glucose meters, blood tests, breathalyzers, etc.) can be used to verify the data obtained, and a personal calibration can be established to correlate the thermoregulatory sweat biomarker levels with the biomarker levels in the blood or other environments of interest.

[0041] refer to Figure 1E In some embodiments, the gel-free sensor 100 includes a plurality of first electrodes 110 extending in a first direction, a plurality of second electrodes 120 extending in the first direction, a first current collector 130 connected to the plurality of first electrodes 110, and a second current collector 132 connected to the plurality of second electrodes 120. In one example, the first electrodes 110 and the second electrodes 120 are alternately arranged in the second direction. In one example, the first direction is perpendicular to the second direction. In some embodiments, the first current collector 130 is connected to one end of each of the first electrodes 110, and the second current collector 132 is connected to one end of each of the second electrodes 120.

[0042] In some embodiments, the first electrode 110 can be used as a working electrode and the second electrode 120 can be used as a reference / counter electrode. In some embodiments, the first electrode 110 may include a PEDOT:PSS-Prussian blue (PB) cathode and the second electrode 120 may include a poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) anode. In some embodiments, the first electrode 110 and the second electrode 120 are solid-state interlaced electrodes (IDE) printed on a styrene-isoprene-styrene block copolymer (SIS) substrate. In some embodiments, the solid-state interlaced electrode (IDE) is modified with glucose oxidase (GOx), which selectively reacts with glucose in fingertip sweat for subsequent detection. In some embodiments, the first electrode 110 and the second electrode 120 extend in the same direction (e.g., the second direction) and are alternately arranged at a predetermined distance. In one example, the predetermined distance between adjacent first electrodes 110 and second electrodes 120 provides an ion path. In some embodiments, the predetermined distance is less than 1 mm.

[0043] In some embodiments, the gel-free sensor 100 may further include a substrate configured to support the first electrode 110 and the second electrode 120 and the first current collector 130 and the second current collector 132. In one example, the substrate includes at least one of glass, silicon, paper, textile, polymeric plastic, or elastomer. In some embodiments, the gel-free sensor 100 may further include a glucose oxidase (GOx) layer formed on the first electrode and the second electrode and the first current collector and the second current collector to selectively react with glucose in a body fluid for detection. In one example, the body fluid includes fingertip sweat.

[0044] The disclosed technology can be implemented in some embodiments to provide a solid-state touch sensor that enables frequent, accurate, non-invasive glucose monitoring.

[0045] FIG. 3A to FIG. 3F Solid-state interdigitated electrodes (IDEs) for rapid glucose sensing using naturally hydrated fingertips are shown. Figure 3A Schematic diagram showing an exploded view of the structure of the printed PEDOT:PSS-based IDE sensor. Figure 3B is a graphic representation of sweat accumulation within a finger groove establishing a connection between a PEDOT:PSS-PB cathode and a PEDOT:PSS anode for subsequent electrochemical reactions. Figure 3C Shown is a diagram demonstrating the use of a gel-free IDE sensor to rapidly and frequently non-invasively sense glucose levels during events that cause glucose fluctuations. Figure 3D The CA curves demonstrating the reusability and reversibility of the sensor capable of repeated sensing are shown. Figure 3E A diagram showing that the gel-free IDE glucose sensor could potentially be used for continuous glucose monitoring throughout the day is shown. Figure 3F Clarke error grids are shown compared to a reference self-monitoring blood glucose (SMBG) test, demonstrating the gel-free IDE sensor for fingertip sweat as a reliable mechanism for blood glucose sensing. Data points were collected from 5 healthy subjects, consisting of 50 measurements performed 20 min before and after meals over 5 days.

[0046] FIG. 4A to FIG. 4G The design and use optimization of a gel-free touch-based IDE sensor is shown. Figure 4A are illustrations of (i) the experimental setup for visualizing sweat on a fingertip and the corresponding optical image of the fingertip when the sensor is pressed, where the indicator turns blue due to sweat in the groove, (ii) the corresponding percentage of area covered by sweat indicated by the color-changing dye, and (iii) the resistance between the anode and cathode versus the pressing time. Figure 4B Shown are (i) schematics of conventional screen-printed electrode (SPE) and IDE designs with controlled inter-electrode distance d, (ii) chronoamperometry (CA) responses of gel-free electrodes to finger sweat in conventional SPE (left) and IDE (right) designs with an inter-electrode distance of 0.25 mm, and (iii) summary of the changes in CA current response to finger sweat with different inter-electrode distances, corresponding to capillary blood glucose levels of 85 mg / dl (402) and 128 mg / dl (404). Figure 4C Shown are (i) the CA curve and (ii) the resulting current signal after different numbers of touches (sweat accumulation) when a finger is pressing the sensor. Figure 4D Shown are (i) CA curves and (ii) resulting current signals at different compression pressures. Figure 4E Shown are (i) the CA response for a subject with stable glucose levels with 6 repeated touches on the hydrogel-covered electrode (412) and the solid-state electrode (414) before a meal, (ii) a bar graph (416, 418) summarizing the current signals, and (iii) the CA response for a subject with decreased glucose levels with 6 repeated touches on the hydrogel-covered electrode (420) and the solid-state electrode (422) after a meal, and (iv) a bar graph (424, 426) summarizing the current signals. Figure 4F The reproducibility of the sensor is shown for five repeated measurements at 3 min intervals: Figure 4F In (i), line 428 indicates fingertip sensing corresponding to a capillary blood glucose (CBG) of 83 mg / dl before a meal, and line 430 indicates fingertip sensing corresponding to a CBG of 132 mg / dl after a meal; in Figure 4FIn (ii), the corresponding bar graphs show the reproducibility of the pre-prandial and post-prandial results, yielding RSDs of 2.4% and 1.9%, respectively. Figure 4G Shown are (i) 20 repeated measurements at 3 min intervals (60 min total) at fasting blood glucose levels, and (ii) the reproducibility of these 20 repeated measurements; RSD 3.9%.

[0047] FIG. 5A to FIG. 5D Calibration and extended on-body evaluation of a gel-free touch-based glucose sensor are shown. Figure 5A Shown are the current responses of the touch-based glucose sensor to the corresponding fingerstick SMGB reference and the corresponding linear regression generated from 5 healthy subjects obtained before and after a meal over the next 5 days. Subjects included males and females aged 22 to 36 years. Figure 5B Shown are (i) a schematic diagram representing the time course of extended continuous glucose monitoring over 170 min, during which volunteers were provided with the same food and drink after 20 min and 110 min of testing, while touch-based glucose sensor and fingerstick SMGB signals were recorded every 5 min and 10 min, respectively, and (ii) touch-based glucose sensor results for three non-diabetic volunteers using the first day calibration and their corresponding fingerstick SMGB conversions. Figure 5C Shown is a schematic diagram representing the time course of an extended 12-hour glucose monitoring experiment during which high-carbohydrate meals were provided to non-diabetic individuals 1 h, 5 h, and 10 h after the start of the test: (i) touch-based glucose sensor and fingerstick SMGB signals were collected every 5 min and 10 min within 1 h after the meal and every 1 h between meals, respectively; (ii) the touch-based glucose sensor results of two non-diabetic volunteers were converted using the day 1 calibration and their corresponding fingerstick SMGB reference. Figure 5D Clarke error grid analysis of the touch-based glucose sensor relative to SMGB glucose as a reference is shown.

[0048] Figure 6 Shown is a staining experiment that visualizes the distribution of sweat along the fingertips over time.

[0049] Fig. 7A and Figure 7B In vitro characterization of the IDE sensor is shown. Fig. 7A Shown are (i) characterization of the IDE sensor in PBS (pH = 7.3), including 2-electrode CV, (ii) CA at different potentials from 0 V to -0.3 V, and (iii) current versus potential plots, indicating that the optimal potential is -0.1 V (cathode to anode). Figure 7BShown are (i) characterization of the IDE sensor in artificial sweat (pH = 7), including 2-electrode cyclic voltammetry, (ii) chronoamperometry at different potentials from 0 V to -0.3 V, and (iii) a plot of current versus potential, indicating that the optimal potential is -0.1 V to -0.15 V (cathode to anode).

[0050] Fig. 8A and Figure 8B In vitro calibration of the IDE glucose sensor is shown. Fig. 8A Shown are (i) the CA of IDE for glucose concentrations ranging from 100 μM to 500 μM in PBS at pH 7.3, and (ii) the resulting PBS calibration plot with a sensitivity of 0.97 nA / μM (n=3, r 2 =0.99). Figure 8B Shown are (i) the CA of IDE for glucose concentrations ranging from 0 μM to 500 μM in artificial sweat at pH 6.0, and (ii) the resulting PBS calibration plot with a sensitivity of 0.97 nA / μM.

[0051] Fig. 9 The selectivity of the IDE glucose sensor is shown: CA responses of the sensor in PBS (blank) and after subsequent addition of 100 μM glucose, lactate, ascorbic acid, acetaminophen, and uric acid, respectively.

[0052] Fig. 10A and Fig. 10B Optimization of the spacing between electrodes is shown. Fig. 10A The CA responses of typical SPE designs with different electrode spacings are shown. Fig. 10B The CA responses of IDE designs with different inter-electrode spacings are shown.

[0053] Fig.11A and Fig. 11B Sensor reproducibility characterization is shown. Fig.11A Shown are the superimposed CA responses of 5 different IDE glucose sensors touched by the same subject with the same finger. Fig. 11B The corresponding results with a RSD of 4.3% are shown.

[0054] FIG. 12A to FIG. 12D Correlation of touch-based glucose levels with fingerstick CBG in extended glucose monitoring trials at 3 h and 12 h is shown. Fig. 12A A 1-day calibration is shown without taking into account any time delay. Fig. 12B A 1 day calibration with a 10 min delay is shown. Fig. 12C A 3 day calibration with a 10 min delay is shown. Fig.12D A 5-day calibration with a 10 min delay is shown. Pearson correlation coefficients are marked in their corresponding subplots.

[0055] Fig.13A and Fig. 13B CEGA with additional calibration and time delay correction is shown. Fig.13A CEGA with (i) 1 day, (ii) 3 days and (iii) 5 days of calibration without considering any time delay is shown. Fig. 13B CEGA with (i) 1 day, (ii) 3 days, and (iii) 5 days calibration when considering a 10 minute delay between CBG and fingertip sweat glucose is shown.

[0056] Type 1 diabetes is a chronic disease that requires frequent blood glucose testing to prevent acute and long-term complications. Common glucose monitoring methods, including finger-prick capillary blood tests and subcutaneous continuous glucose monitors, are painful and invasive, respectively, while recent non-invasive epidermal sensors are limited in practicality and reliability. The disclosed technology can be implemented in some embodiments to provide a convenient, fast and accurate method using an interlaced electrode converter for frequent touch-based sweat glucose biosensing that utilizes passive sweat from the fingertips. The interlaced design establishes a solid-state interface, eliminating the need for hydrogels to collect sweat, which greatly simplifies the sensing workflow and imparts stability and reusability. The sensor can be reused for all-day glucose self-monitoring and provides reliable glucose data with a low average absolute relative difference of 8.69%, comparable to commercial finger-prick and continuous glucose monitors. The new scheme based on some embodiments provides convenient, practical and painless glucose sensing, promoting frequent self-testing and improved diabetes self-care.

[0057] Diabetes is a global health concern, ranking among the leading causes of death. Frequent monitoring of blood glucose levels is essential for understanding disease progression and optimizing its control. Although diabetic patients have relied on self-monitoring blood glucose (SMBG) by finger pricking multiple times a day for the past three decades, the painful, inconvenient and invasive nature of such finger pricking steps has compromised patient compliance and greatly reduced the frequency of testing. Continuous glucose monitoring (CGM) addresses these limitations of SMBG and provides significant improvements in the management of diabetes. Although CGM eliminates the need for finger pricking and provides more understanding from continuous data, it still uses expensive invasive (e.g., about 10 mm long) needles, requires daily SMBG calibration, and faces challenges of biofouling, long stabilization time, glucose time delay and limited lifespan. Although alternatives such as non-invasive sweat and interstitial fluid (ISF) glucose sensors have been proposed recently, their practicality is largely hindered by complex biofluid extraction mechanisms (e.g., exercise, sweat-inducing drugs, reverse iontophoresis), which may induce unnatural metabolic activity or dilution, affecting the correlation with blood glucose concentration. In fact, it was demonstrated that sweat glucose can accurately reflect blood glucose levels when sweat is properly harvested. Recent advances have cleverly exploited the direct sampling of passive thermoregulatory sweat from high sweat rate fingertips for chemical sensing, leading to the monitoring of cortisol, levodopa, glucose, caffeine, lactate, and ascorbic acid concentrations. However, such touch-based sensing relies on hydrogels as the sweat collection interface (made of agarose or polyvinyl alcohol) mounted on the sensor, which leads to major challenges and errors due to analyte carryover, dilution, and solvent evaporation. Therefore, the use of hydrogel interfaces suffers from inconsistent sensing results and requires inconvenient and lengthy gel replacement, thus greatly hindering the reliability, repeatability, durability, simplicity, and overall practicality of such techniques.

[0058] The disclosed technology can be implemented to address the above-mentioned problems by providing a reusable solid-state, touch-based electrochemical sensing scheme for reliable, frequent and extended glucose monitoring. To eliminate the need for hydrogels, the sensor relies on a solid-state interlaced electrode (IDE) design consisting of a poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) anode and a PEDOT:PSS-Prussian blue (PB) cathode printed on a styrene-isoprene-styrene block copolymer (SIS) substrate. These printed IDE electrodes are modified with glucose oxidase (GOx), which selectively reacts with glucose in fingertip sweat for subsequent detection ( Figure 3AThe staggered PEDOT:PSS electrode design enables direct touch-based measurement of sweat glucose without any hydrogel or ion-conductive interface, where passive sweat diffuses rapidly along the grooves of the fingertips, establishing an ionic pathway between the anode and cathode of the IDE ( Figure 3B ). The use of conductive PEDOT:PSS polymers imparts ion transport and low electrode impedance, which are advantageous for solid-state bioelectronic interfaces. Relying on rapid natural sweat on the fingertips, the solid-state IDE biosensor can provide accurate non-invasive sweat sensing within 90s, including 60s of sweat accumulation followed by 30s of chronoamperometry (CA) at a low voltage of -0.1V to provide a highly selective current response that can be easily calibrated to blood glucose. Such a simple, rapid user-friendly painless glucose self-test provides a high sensing frequency, comparable to state-of-the-art CGM technology (1 data point every 1.5min to 15min), but in a completely non-invasive manner. Therefore, this solution allows users to closely track their blood glucose levels and capture dynamic events involving rapidly fluctuating concentrations ( Figure 3C ). Furthermore, the elimination of hydrogel and associated chemical accumulation allows for repeated use of the same sensor throughout the day (after a quick, gentle wipe with a tissue) and eliminates the need for any stabilization time. The sensor produces a highly reproducible signal upon repeated use and is highly reversible to follow dramatic fluctuations in blood glucose concentrations ( Figure 3D A single sensor strip can be reliably used for continuous glucose testing throughout the day to allow users to track their glucose levels and detect potential glycemic abnormalities conveniently and closely ( Figure 3E ). Initially, on the first day, a simple 2-data-point personalized calibration (at different blood glucose levels) was used to fully account for inter-person variability (e.g., sweat rate). The sensor provided highly accurate blood glucose concentration data that closely matched commercial fingerstick capillary blood glucose (CBG) levels with a short time delay and was characterized by a low mean absolute relative difference (MARD) of 8.69% and a Region A proportion of 89.4% in the Clarke Error Grid Analysis (CEGA) ( Figure 3F ), which is comparable to the accuracy of commercial CGM and fingerstick SMGB.

[0059] To make full use of the small amount of sweat on the fingertips, the sweat distribution on the fingertip surface was closely examined by using a color-changing bromocresol green dye, which turns blue when in contact with sweat. Figure 4A As shown in Fig. 1, a SIS substrate uniformly coated with a thin layer of dye was placed on a glass slide, and a video was taken to record the color change of the dye when a clean, dry finger was pressed on the substrate ( Figure 6). As time went on, most of the grooves were covered with sweat within 60 s, thus establishing a conductive path between the anode and cathode ( Figure 4A ii). As the color of the dye darkens over time, no additional area is covered by sweat. This is consistent with the measurement of the internal resistance between the two electrodes, which is mostly stable after 60 s ( Figure 4A iii).

[0060] The performance of the gel-free touch-based sensor for glucose monitoring was first characterized in vitro using glucose in phosphate buffered saline (PBS) at pH 7. The optimal potential was optimized at -0.1 V between the cathode and anode, which resulted in the highest CA response. Similarly, the sensor was evaluated in artificial sweat (with a lower pH of 6), showing that the optimal potential and response were not affected by the lower pH ( Fig. 7A , Figure 7B , Fig. 8A and Figure 8B The advantages of solid-state IDE electrodes were then tested using the fingertips of human subjects in comparison to conventional screen-printed electrode (SPE) sensor designs as well as hydrogel sweat collection interfaces. Compared to the SPE disc design, the IDE arrangement reduces the spacing between electrodes while maximizing the number of electrical connections between the anode and cathode ( Figure 4B i). As a result, when sensing from the same finger, IDE has significantly higher sensitivity than SPE, even with similar inter-electrode distances ( Figure 4B ii). Generally, the sensitivity increases when the inter-electrode spacing is reduced to 0.25 mm, which is used in subsequent measurements ( Figure 4B iii. Fig. 10A and Fig. 10B ). Evaluation of different sweat accumulation times before CA measurement showed that the response gradually increased with contact time until 45 s, after which it began to stabilize ( Figure 4C ), which is consistent with Figure 4A The pressing force of the electrode was also optimized; the results ( Figure 4D ) shows that 5N per finger is sufficient to achieve a stable signal.

[0061] Thus, the IDE design allows solid-state contact-based fingertip sensing, providing significant advantages over common hydrogel-based sweat collection mechanisms in terms of simplicity, reusability, test frequency, and data reproducibility. As a comparison, the same finger was tested repeatedly on the same sensor with and without hydrogel under conditions of stable and declining glucose levels (30 min before and after a meal, respectively). Figure 4E i to Figure 4EAs shown in Figure ii, under conditions of constant glucose levels, the hydrogel-covered sensor shows an increased current signal due to glucose carryover and accumulation from repeated touches, while the solid-state IDE sensor shows good stability with negligible differences from these repeated touches. In contrast, under conditions of decreasing glucose levels ( Figure 4E iii to Figure 4E iv), the solid-state IDE sensor can accurately capture dynamically decreasing glucose concentrations, while the hydrogel-covered sensor shows a slowly increasing response due to the combination of the competitive effect of decreasing glucose concentration and its accumulation in the gel, resulting in an unrealistically increased response associated with such a carryover effect. The reproducibility of the sensor at different glucose concentrations was investigated from 5 repeated tests in the fasting state (CBG = 83 mg / dl) and 20 min after a meal (CBG = 132 mg / dl). Figure 4F ). For these repeated touch-based measurements, highly reproducible CA signals were observed, resulting in RSD values ​​of 2.4% and 1.9%, respectively. In addition, the repeatability of the glucose sensor was evaluated over an extended period of 60 min, involving 20 repeated tests at 3 min intervals at fasting blood glucose levels ( Figure 4G The highly reproducible current signal over this long series (with a low RSD value of 3.9% (n=20)) shows good repeatability for repeated frequent measurements. In addition, the selectivity and reproducibility of the sensor were characterized ( Fig. 9 , Fig.11A and Fig. 11B ).

[0062] After system optimization and characterization, the accuracy of the touch sensor was evaluated with five healthy nondiabetic male and female subjects aged 22 to 36 years. Due to individual differences (e.g., sweat rate, fingertip size), each subject was initially tested before and 20 min after a meal to construct a personalized calibration between the CA signal of the gel-free touch-based glucose sensor and the CBG levels obtained from the fingerstick SMGB ( Figure 5A ). Of the 10 data points generated over the first 5 days, five subjects had achieved calibrations with Pearson values ​​greater than 0.98, 0.99, 0.96, 0.96, and 0.99, respectively, indicating a consistent correlation between glucose in passive sweat from the fingertips and fingertip blood levels across days. Such consistency eliminated the need for repeated recalibration; therefore, only the data points from Day 1 were used for subsequent personalized calibrations.

[0063] Table 1: Statistics of sensors using different calibration methods

[0064] The ability to use a touch-based, gel-free glucose sensor to replace fingerstick SMGB for frequent, noninvasive, and rapid glucose sensing was first assessed over a 3-h period during which all subjects consumed a high-calorie meal followed by a sugar-rich juice drink while performing touch-based sensing (with the same sensor) every 5 min and fingerstick CBG reference measurements at 10-min intervals ( Figure 5B i). like Figure 5B As shown in Figure ii, for all three subjects, glucose levels (estimated from the first day calibration) have shown good agreement with the reference CBG concentration. To further explore the solid-state IDE glucose sensor as a potential alternative to CGM, extended all-day glucose monitoring was performed over a 12-hour period. During this time, the subjects consumed breakfast, lunch, and dinner; in parallel, touch sensing and finger stick CBG measurements were performed every 5 and 10 minutes, respectively, within one hour after the meal, in addition to hourly measurements between meals ( Figure 5C i). The results from both subjects showed a continuous dynamic profile of glucose concentration throughout the day, with consistent high values ​​and temporal trends between the two measurement methods ( Figure 5C ii). Of note, a lag of approximately 10 min between fingertip glucose levels and CBG was observed in all subjects in both the 3-h and 12-h trials, which is consistent with previous reports and reflects the diffusional transport of glucose from capillaries to apocrine sweat glands. Similar time delays are observed in commercial CGM devices and are often accounted for by various prediction algorithms that improve accuracy. By accounting for the 10-min time delay, the touch-based glucose calibration can be adjusted to further improve the correlation of the 5 trials, as shown in Figure 2. FIG. 12A to FIG. 12D , Fig.13A and Fig. 13B And as shown in Table 1.

[0065] Mean absolute relative difference (MARD) and Clarke error grid analysis (CEGA) are common methods to evaluate the accuracy and reliability of glucose sensing technologies. Commercial CGM systems are typically characterized by MARD values ​​of 9% to 14%. The gel-free touch-based sensor was characterized by a MARD of 8.69% (data size n=160), which reflects its high accuracy, comparable to the accuracy of commercial glucose monitoring devices. Using additional calibration (relative to blood; within the first 3 to 5 days, rather than the first day), the MARD did not show significant improvement, while the MARD of the sensor could be further reduced to 4.76% when time delay was taken into account (Table 1). CEGA evaluates the reliability of glucose monitoring technology by dividing the grid into separate regions A to E, where region A corresponds to values ​​within 20% of the reference and means no impact on clinical effect. As Figure 5DAs shown, the solid-state, gel-free touch-based glucose sensor had 87.9% of the data points falling in region A, and 100% of all values ​​falling in the combined A plus B regions, indicating high accuracy and very low likelihood of misdiagnosis of hypoglycemia and hyperglycemia. Notably, considering the 10 min time delay resulting in even higher sensor reliability, with 98% of the data in region A, the additional calibration data points did not significantly improve accuracy ( Fig.13A and Fig. 13B ).

[0066] The disclosed technology can be implemented in some embodiments to provide a highly accurate, simple and fast glucose sensing scheme using an interlaced solid-state PEDOT:PSS-based electrode that utilizes passive sweat from the fingertips to achieve reliable near real-time non-invasive monitoring of glucose levels. Compared to conventional hydrogel-based SPE sensors, eliminating the need for sweat-collecting hydrogel interfaces greatly simplifies the operation of allowing frequent repeated measurements throughout the day while providing excellent analytical performance. Compatible with different subjects, the sensor can quickly establish personalized calibration (only from the initial 2 fingerstick measurements), showing considerable prospects for replacing painful, frequent finger-piercing SMBG and invasive CGM technology for extended all-day continuous glucose monitoring. The new scheme provides high accuracy with low MARD and good CEGA metrics, which are comparable to those of commercial glucose sensing technologies; and painless (bloodless and needleless) rapid operation. The same low-cost sensor can be used without any re-stabilization to perform more than 50 measurements in a day. Compared with traditional SMBG, such convenient touch-based sensing greatly increases the frequency of self-testing to provide enhanced diabetes control. The disclosed technology may also be implemented in some embodiments to enable large-scale validation using different subjects and further improve speed and simplicity, leading to the development of advanced blood-free calibration processes and prediction algorithms, as well as an improved understanding of the fingertip passive sweating phenomenon and the role of electrode geometry in the anhydrous gel IDE setting. Translating such contact-based sensing into a wearable device for passive, continuous glucose monitoring during the day and night will further promote its practical use as a true CGM alternative. Combined with engineering efforts to create user-friendly sensor prototypes, these developments can lead to highly reliable painless rapid and frequent glucose self-testing for home and other decentralized settings for improved management of diabetes, as well as simplified and accurate non-invasive monitoring of other key sweat biomarkers.

[0067] In some embodiments, based on some embodiments of the disclosed technology, graphite, toluene, acetone, ethanol, glutaraldehyde, D-(+)-glucose, glucose oxidase (GOx), Ag flakes, potassium chloride (KCl), sodium chloride (NaCl), anhydrous sodium phosphate, Prussian blue, and sodium dodecylbenzene sulfonate (DBSS) can be used to make staggered electrodes. In some embodiments, based on some embodiments of the disclosed technology, styrene-ethylene-butylene-styrene (e.g., SEBS G1645) triblock copolymers can be used to make staggered electrodes. In some embodiments, based on some embodiments of the disclosed technology, screen-printable PEDOT:PSS paste can be used to make staggered electrodes.

[0068] staggered Electrode fabrication

[0069] In some embodiments, the IDE sensor can be made using layer-by-layer screen printing with four customized inks: electrochromic poly(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) ink, silver ink for interconnection, and insulating resin composed of SEBS. The PEDOT:PSS ink can be formed using an ink mixture prepared using 1g of PEDOT:PSS paste, 0.2mL of toluene, 0.15mL of DBSS (75mg / ml in DI water), and 0.0135mL of fluorosurfactant FS-65. To prepare PEDOT:PSS-PB ink, similar components can be used, with an additional 20mg of PB powder added per 1g of mixture. Stretchable silver ink can be synthesized. In some embodiments, silver flakes, toluene, and SEBS can be mixed in a weight ratio of 4:2.37:0.63. All inks can be homogenized by mixing in a dual asymmetric centrifugal mixer, for example, mixing at a speed of 1900RPM for 5min. The insulating resin was prepared by dissolving SEBS in toluene solution (weight ratio of 4:10). The solution was then mixed at 1900 RPM for 20 min or until the SEBS was completely dissolved in the solution.

[0070] After preparing the ink, a flexible substrate for printing fingerprint sensors was fabricated. With the help of a stainless steel rod, a SIS layer of 1000 μm was formed on top of a PET plastic sheet. The thin layer was dried at 60 °C for 30 min. The printed electrode pattern (electrode area of ​​0.02 cm) was designed in the software. 2 ) and transferred it to a stainless steel plate (12×12in 2) was etched on to make a metal template. The electrochemical system consisting of a working electrode and a reference electrode was screen printed using an MPM-SPM semi-automatic screen printer. The printing process consisted of first printing the reference electrode on the SIS substrate using PEDOT:PSS ink, followed by a 30 min curing step at 120°C. Next, the working electrode was printed using PEDOT:PSS-PB ink, and similar drying conditions were applied after printing the electrode. Subsequently, a silver interconnected pattern was printed on top of the electrode system, followed by a 15 min curing step at 90°C. SEBS resin was used to insulate the interconnections. Finally, the insulator was dried at 90°C for 10 min to obtain the printed IDE electrode.

[0071] The IDE electrode was modified by drop casting a mixture of 6 μL of glucose oxidase (20 mg / mL in PBS, 0.1 M pH 7.3) and 3 μL of glutaraldehyde (1% in DI water) onto the exposed electrode surface. After modification, the electrode was stored in a refrigerator at 4°C overnight.

[0072] In vitro sensor characterization

[0073] In vitro characterization of the touch-based glucose sensor was performed using 0.1 M PBS (pH 7.3) and artificial sweat (AS, pH 6.0). Two-electrode cyclic voltammetry was performed from -0.35 V to 0.55 V to observe the redox peaks of PB molecules at 0.02 V and -0.08 V in PBS and 0.12 V and -0.04 V in AS. The optimization of the applied potential at different potentials decreasing from 0 V to -0.3 V (with a step size of 50 mV) was studied. Based on the current response at different potentials, -0.1 V was selected and used for subsequent in vitro and in vivo experiments ( Fig. 7A and Figure 7B Under the optimized conditions, the glucose level was varied from 0 μM to 500 μM in 100 μM increments and showed good linearity in both PBS and AS ( Fig. 8A and Figure 8B ). In addition, selectivity tests were performed in PBS followed by the addition of 100 μM of glucose, lactic acid (LA), ascorbic acid (AA), acetaminophen (AP), and uric acid (UA) ( Fig. 9 ).

[0074] Chemical fingerprint sensing on the body

[0075] Fingerprint sensing was performed on healthy consenting individuals, and the protocol approved by the Institutional review board at the University of California, San Diego was strictly followed. Volunteers were asked to place their index fingers on the top of the sensor for all body evaluations. Glucose levels were verified using a commercial blood glucose meter. Before using the sensor, volunteers were asked to clean their hands with water and soap. Body results were obtained using a desktop Autolab potentiostat / galvanostat 204 from Metrohm. A 30s chronoamperometric potential step of -0.1V was used during all experiments. In order to collect blood glucose levels, each individual's finger was pierced and a small drop of blood was analyzed. Then, the fingertip glucose signal was measured by touching the sensor for 60s. Next, two chronoamperometric measurement steps were performed to quantify the current signal. The last current value from the second scan was taken as the corresponding sweat glucose level. After each sensing session, the sensor was first moistened with deionized water, and then gently wiped with a paper towel to dry the sensor for the next measurement.

[0076] Personalized calibration experiment

[0077] Blood and fingertip glucose signals were obtained from five volunteers for 5 consecutive days in the fasting state and 20 min after consuming a sugar-rich meal. The current and blood glucose values ​​were plotted together and a linear fit was used to obtain the slope b and intercept a for each subject using the data obtained from a given day. To obtain the predicted glucose concentration for each subject, the following formula was used: BG=a+bi where “i” represents the current value obtained after the second chronoamperometric scan.

[0078] Extended on-body experiment

[0079] Three subjects were recruited for a 3-hour monitoring experiment. Fasting glucose levels were recorded for 20 minutes, followed by a meal. After 90 minutes, a high-sugar beverage was provided to each subject. At the same time, blood and fingertip glucose were monitored every 10 minutes and 5 minutes, respectively. Two subjects were recruited for a 12-hour experiment. The experiment was started by monitoring blood and fingertip glucose every hour. Regular monitoring of the two parameters changed only after eating at 1 hour, 5 hours, and 10 hours after the start of the experiment. During these time periods, blood and fingertip glucose were monitored every 10 minutes and 5 minutes, respectively.

[0080] Achieving strict glycemic control for effective management of diabetes requires frequent or continuous measurement of glucose. Non-invasive glucose monitoring has been considered the "holy grail" of next-generation biosensing technology due to its huge impact on a large population and a large commercial market. However, after decades of development, diabetic patients who rely on multiple self-monitoring of blood glucose to prevent life-threatening complications still rely on painful and inconvenient finger-piercing blood glucose meters and expensive and invasive continuous glucose monitors (CGMs). Although non-invasive glucose sensing technologies based on sweat and interstitial fluid have been proposed, their practical implementation is still limited due to their lengthy and complex biofluid extraction processes. In response to these challenges, our team recently explored the use of passive sweat from fingertips (due to their high natural sweating rate) for chemical sensing. Such fingertip-based contact sensing uses hydrogels to extract sweat from fingertips and is capable of chemical monitoring, and faces various limitations, such as analyte carryover and dilution, solvent evaporation, and inconvenient gel placement and storage, which hinders its practical application for tracking dynamically changing concentrations.

[0081] In view of the above problems, the disclosed technology can be implemented in some embodiments to provide a reusable solid-state touch-based electrochemical sensing solution for reliable and convenient frequent extended glucose monitoring. In addition, the disclosed technology can be implemented in some embodiments to provide a unique solid-state interlaced electrode converter for direct touch-based glucose monitoring without the need for any sweat extraction mechanism. When touched by a fingertip, the solid interface is quickly covered by a sweat layer on the interlaced electrodes, which quickly records glucose levels without any pretreatment or incubation. Such a painless biosensor is characterized by reusability and speed, so the test frequency can be greatly increased compared to traditional finger punctures, thereby extending the tracking of dynamic glucose changes throughout the day. Unlike early studies based on sweating stimulated by exercise or iontophoresis (which reported a low correlation with blood glucose), natural sweat is currently used to provide high accuracy in predicting blood glucose levels related to a single first-day personalized calibration. In 160 trials over multiple full-day glucose monitoring sessions on subjects with varying backgrounds, the sensor closely matched the blood glucose temporal profile, delivering highly accurate blood glucose concentration data as shown by a low mean absolute relative difference (MARD) of 8.15%, which compares favorably to the accuracy of commercial blood glucose strips and CGMs (typically 9% to 14%). Utilizing the new user-friendly, non-invasive biosensing approach and its attractive features of high-quality data, the disclosed technology can be implemented in some embodiments to enable non-invasive glucose monitoring, which can become an important component of diabetes self-care.

[0082] Fig.14An example method 1400 for measuring biomarkers in a biological fluid based on some embodiments of the disclosed technology is shown.

[0083] In some embodiments, method 1400 includes, at 1402, contacting the sensor device with the skin of the subject, and, at 1404, measuring biomarkers in a biological fluid from the skin of the subject using the sensor device. The sensor device may include a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each of the first electrodes; and a second current collector connected to the plurality of second electrodes at one end of each of the second electrodes, wherein the first electrodes and the second electrodes are alternately arranged, and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0084] Therefore, various implementations of the features of the disclosed technology can be made based on the above disclosure, including the examples listed below.

[0085] Example 1. A sensor device comprising: A substrate; a plurality of first electrodes and a plurality of second electrodes formed on the substrate; a first current collector formed on the substrate and connected to the plurality of first electrodes at one end of each first electrode; and a second current collector formed on the substrate and connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes and the second electrodes are alternately arranged and adjacent first electrodes and second electrodes are spaced a predetermined distance from each other.

[0086] Example 2. The sensor device of example 1, wherein the plurality of first electrodes comprises working electrodes and the plurality of second electrodes comprises reference electrodes or counter electrodes.

[0087] Example 3. The sensor device of example 1, wherein the plurality of first and second electrodes comprises at least one of a metal, a carbonaceous material, a doped conductive metal oxide, a conductive polymer, or a metal salt.

[0088] Example 4. The sensor device of example 3, wherein the metal comprises at least one of silver, gold, platinum, copper, titanium, or brass.

[0089] Example 5. The sensor device of example 3, wherein the carbonaceous material comprises at least one of graphite, carbon nanotubes, graphene, laser-induced graphene, glassy carbon, or reduced graphene oxide.

[0090] Example 6. The sensor device of example 3, wherein the doped conductive metal oxide comprises indium tin oxide (ITO).

[0091] Example 7. The sensor device of Example 3, wherein the conductive polymer comprises at least one of polyaniline, polypyrrole, polythiophene, or poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS).

[0092] Example 8. The sensor device of Example 3, wherein the metal salt comprises silver chloride.

[0093] Example 9. The sensor device of Example 3, wherein the plurality of first and second electrodes include an electroactive redox mediator, the electroactive redox mediator including at least one of a quinone, Prussian blue, an osmium-containing redox mediator, a ruthenium-containing mediator, an organic dye, tetrathiafulvalene, tetrathiafulvalene-tetracyanoquinodimethane, or ferrocene.

[0094] Example 10. The sensor device of Example 9, wherein the quinone comprises at least one of benzoquinone, naphthoquinone (NQ), anthraquinone, hydroquinone, or chlorohydroquinone.

[0095] Example 11. The sensor device of Example 9, wherein the osmium-containing redox mediator comprises osmium bipyridine.

[0096] Example 12. The sensor device of Example 9, wherein the ruthenium-containing medium comprises ruthenium bipyridine.

[0097] Example 13. The sensor device of Example 9, wherein the organic dye comprises at least one of methylene blue, toluidine blue O, methylene green, azure A and B, or thionine.

[0098] Example 14. The sensor device of Example 1, wherein the substrate comprises a polymer substrate, and wherein the plurality of first and second electrodes comprise one or more solid interleaved electrodes (IDE) deposited on the polymer substrate. In some embodiments, the deposition can be performed using a planar deposition method. In some embodiments, the first and second electrodes comprise a material deposited on the substrate using at least one of screen printing, inkjet printing, flexographic printing, sputtering, lithography, electrodeposition, or direct ink writing.

[0099] Example 15. The sensor device of example 1, wherein the substrate comprises at least one of glass, silicon, paper, textile, polymeric plastic, or elastomer.

[0100] Example 16. The sensor device of Example 15, wherein the substrate comprises the polymeric plastic or the elastomer and comprises one or more polymer layers, wherein the one or more polymer layers comprise at least one of the following: polyethylene, polypropylene, polyethylene terephthalate, polyvinyl chloride, polystyrene, a polysaccharide-based polymer, a polystyrene-based block copolymer, a polysaccharide, polyvinyl alcohol, or polyethylene vinyl acetate.

[0101] Example 17. The sensor device of Example 16, wherein the polystyrene-based block copolymer comprises at least one of polystyrene-polyethylene-polybutylene-polystyrene (SEBS), polystyrene-polyisoprene-polystyrene (SIS), or polystyrene-polybutylene-polystyrene (SBS).

[0103] Example 18. The sensor device of Example 16, wherein the polysaccharide comprises at least one of starch polymer, cellulose, nitrocellulose, chitosan, ethyl cellulose, or methyl cellulose.

[0104] Example 19. The sensor device of claim 1, wherein the substrate comprises at least one of a fluorinated polymer, a copolymer of the fluorinated polymer, poly(vinyl difluoroethylene), tetrafluoropropylene, or hexafluoropropylene.

[0105] Example 20. The sensor device of claim 19, wherein the copolymer of fluorinated polymer comprises poly(tetrafluoroethylene).

[0106] Example 21. The sensor device of example 1, wherein the sensor device is configured to be placed directly on a skin surface to directly interact with natural sweat without requiring a biofluid collection mechanism including microfluidics or hydrogels.

[0107] Example 22. The sensor device of Example 21, wherein the biological fluid comprises fingertip sweat.

[0108] Example 23. The sensor device according to Example 1, wherein the predetermined distance between the adjacent first and second electrodes includes an ion path for signal transduction when in contact with the user's skin surface through natural perspiration, and wherein the ion path is only established when in contact with the skin and is eliminated when the sensor is removed from the skin surface.

[0109] Example 24. The sensor device of example 1, wherein the predetermined distance is less than 1 mm.

[0110] Example 25. The sensor device of example 1, wherein the plurality of first electrodes and the plurality of second electrodes are interleaved with each other, and wherein the interleaved electrodes are arranged in parallel, radially, or concentrically.

[0111] Example 26. The sensor device according to Example 1, further comprising at least one of an enzymatic transduction layer or a non-enzymatic transduction layer formed on the first and second electrodes and the first and second current collectors to selectively react with a biomarker in a body fluid for detection.

[0112] Example 27. The sensor device of Example 26, wherein the enzymatic transduction layer comprises an enzymatic material, the enzymatic material comprising at least one of the following: glucose oxidase, glucose dehydrogenase, lactate oxidase, lactate dehydrogenase, alcohol oxidase, alcohol dehydrogenase, tyrosinase, ascorbate oxidase, urease, uricase, xanthine oxidase, tyrosinase, glutamate oxidase, laccase, hydroxybutyrate dehydrogenase, catalase, or bilirubin oxidase.

[0113] Example 28. The sensor device of Example 26, wherein the non-enzymatic transduction layer comprises an electroactive non-enzymatic material comprising at least one of metal nanoparticles, metals, nanozymes, or ion-selective materials.

[0114] Example 29. The sensor device of Example 28, wherein the metal nanoparticles include at least one of gold nanoparticles, platinum nanoparticles, or silver nanoparticles.

[0115] Example 30. The sensor device of Example 28, wherein the metal comprises at least one of copper or nickel.

[0116] Example 31. The sensor device of Example 28, wherein the ion selective material comprises at least one of a hydrogen ion carrier, a sodium ion carrier, and a potassium ion carrier.

[0117] Example 32. The sensor device of Example 26, wherein at least one of the enzymatic transduction layer or the non-enzymatic transduction layer comprises at least one of the following: an enzyme cofactor or a cross-linking chemical deposited below, deposited with, or deposited on at least one of the enzymatic transduction layer or the non-enzymatic transduction layer.

[0118] Example 33. The sensor device of Example 32, wherein the enzyme cofactor comprises at least one of nicotinamide adenine dinucleotide, flavin adenine dinucleotide, flavin mononucleotide, heme, or ascorbic acid.

[0119] Example 34. The sensor device of Example 32, wherein the crosslinking chemical comprises at least one of glutaraldehyde, epoxy resin, dihydrazide, bisacrylamide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide / N-hydroxysuccinimide (EDC / NHS), a stabilizer, a polymer, or a surfactant.

[0120] Example 35. The sensor device of Example 34, wherein the stabilizer comprises at least one of bovine serum albumin, human serum albumin, glycerol, or polyphenylene diamine.

[0121] Example 36. The sensor device of Example 34, wherein the polymer comprises at least one of polyethyleneimine, polyurethane, polyvinyl alcohol, polyvinyl pyrrolidone, chitosan, or Nafion.

[0122] Example 37. The sensor device of Example 34, wherein the surfactant comprises at least one of sodium dodecyl sulfate, sodium dodecylstyrene sulfonate, Triton X-100, Triton X-114, or Tween 80.

[0123] Example 38. The sensor device according to Example 1 further comprises: a signal transduction layer disposed on the first electrode and the second electrode to functionalize the first electrode and the second electrode for a biomarker; and a protective layer on the signal transduction layer for protecting the signal transduction layer.

[0124] Example 39. The sensor device of Example 38, wherein the protective layer comprises at least one of Nafion, chitosan, polyethyleneimine, polyurethane, polyvinyl alcohol, polyvinyl chloride, poly(vinyl difluoride), poly(tetrafluoroethylene), tetrafluoropropylene, hexafluoropropylene, starch polymer, cellulose, nitrocellulose, chitosan, ethyl cellulose, or methyl cellulose.

[0125] Example 40. The sensor device of Example 1, wherein the sensor device is configured to selectively react with a biomarker in a body fluid for detection, wherein the biomarker comprises at least one of: glucose, lactate, alcohol, levodopa, creatinine, urea, uric acid, bilirubin, hydroxybutyrate, vitamins, oxygen, ions, hormones, opioids, or cannabinoids.

[0126] Example 41. The sensor device of Example 40, wherein the vitamin comprises ascorbic acid.

[0127] Example 42. The sensor device of Example 40, wherein the ions include at least one of protons, sodium, potassium, chloride, fluoride, calcium, zinc, lead, cadmium, or mercury.

[0128] Example 43. The sensor device of Example 40, wherein the hormone comprises at least one of cortisol, adrenaline, or insulin.

[0129] Example 44. The sensor device of example 1, wherein the sensor device is integrated with an additional sensor for measuring a physical parameter when in contact with the skin, wherein the physical parameter comprises at least one of temperature, humidity, or pressure.

[0130] Example 45. The sensor device of example 1, wherein the sensor device is integrated with an additional sensor for measuring a physiological parameter when in contact with the skin, wherein the physiological parameter comprises blood oxygen level, heart rate, fingerprint pattern, or blood pressure.

[0131] Example 46. A sensor device comprising a plurality of electrode arrays for simultaneously or sequentially sensing a plurality of biomarkers of a physiological parameter, wherein each of the electrode arrays comprises: a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each first electrode; and a second current collector connected to the plurality of second electrodes at one end of each second electrode, wherein the first electrodes and the second electrodes are alternately arranged, and adjacent first electrodes and second electrodes are spaced a predetermined distance apart from each other.

[0132] Example 47. A sensor array comprising a plurality of sensor devices according to any one of Examples 1 to 46, wherein the plurality of sensor devices are formed on a substrate for simultaneously or sequentially sensing a plurality of biomarkers in a biological fluid from different locations of a body.

[0133] Example 48. A method comprising: placing the sensor device of any one of claims 1 to 47 in contact with the skin of a subject; and measuring a biomarker in a biological fluid from the skin of the subject using the sensor device.

[0134] Example 49. The method of Example 48, wherein the biomarker comprises at least one of glucose, lactate, alcohol, levodopa, creatinine, urea, uric acid, bilirubin, hydroxybutyrate, vitamins, oxygen, ions, hormones, opioids, or cannabinoids.

[0135] Example 50. The method of Example 48, further comprising measuring at least one of a physical parameter or a physiological parameter together with the biomarker, The physical parameter includes at least one of temperature, humidity or pressure, and the physiological parameter includes at least one of skin resistance, temperature, blood oxygen level, heart rate, fingerprint pattern or blood pressure.

[0136] The embodiments of the subject matter and functional operations described in this patent document can be implemented in various systems, digital electronic circuits, or in computer software, firmware or hardware, including the structures disclosed in this specification and their structural equivalents, or a combination of one or more of them. The embodiments of the subject matter described in this specification can be implemented as one or more computer program products, that is, one or more modules of computer program instructions encoded on a tangible and non-transitory computer-readable medium for execution by a data processing device or controlling the operation of the data processing device. The computer-readable medium can be a machine-readable storage device, a machine-readable storage substrate, a memory device, a material composition that implements a machine-readable propagation signal, or a combination of one or more of them. The term "data processing unit" or "data processing device" includes all devices, devices and machines for processing data, including, for example, a programmable processor, a computer or multiple processors or computers. In addition to hardware, the device may include code that creates an execution environment for the computer program in question, for example, code that constitutes processor firmware, a protocol stack, a database management system, an operating system, or a combination of one or more of them.

[0137] A computer program (also referred to as a program, software, software application, script, or code) may be written in any form of programming language (including compiled or interpreted languages) and may be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment. A computer program does not necessarily correspond to a file in a file system. A program may be stored as part of a file that holds other programs or data (e.g., one or more scripts stored in a markup language document), in a single file dedicated to the program in question, or in multiple coordinated files (e.g., files storing one or more modules, subroutines, or portions of code). A computer program may be deployed to execute on one computer or on multiple computers located at one site or distributed across multiple sites and interconnected by a communications network.

[0138] The processes and logic flows described in this specification may be performed by one or more programmable processors executing one or more computer programs to perform functions by operating on input data and generating output. The processes and logic flows may also be performed by, and the device may be implemented as, a special purpose logic circuit, such as an FPGA (field programmable gate array) or an ASIC (application specific integrated circuit).

[0139] Processors suitable for executing computer programs include, for example, general and special purpose microprocessors, and any one or more processors of any type of digital computer. Typically, the processor will receive instructions and data from a read-only memory or a random access memory or both. The basic elements of a computer are a processor for executing instructions and one or more memory devices for storing instructions and data. Typically, a computer will also include or be operably connected to receive data from or transmit data to or both of one or more large-capacity storage devices (such as magnetic disks, magneto-optical disks, or optical disks) for storing data. However, a computer does not necessarily have such a device. Computer-readable media suitable for storing computer program instructions and data include all forms of non-volatile memory, media, and memory devices, including, for example, semiconductor memory devices, such as EPROM, EEPROM, and flash memory devices. The processor and memory can be supplemented by or incorporated in a dedicated logic circuit.

[0140] It is intended that the present specification and drawings be regarded as exemplary only, wherein exemplary means example. As used herein, the singular forms "a", "an", and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. In addition, the use of "or" is intended to include "and / or", unless the context clearly indicates otherwise.

[0141] Although this patent document includes many details, these should not be interpreted as limitations on the scope of any invention or the scope that may be claimed, but should be interpreted as descriptions of features that may be unique to a particular embodiment of a particular invention. Certain features described in the context of separate embodiments in this patent document may also be implemented in combination in a single embodiment. Conversely, the various features described in the context of a single embodiment may also be implemented in multiple embodiments individually or in any suitable sub-combination. In addition, although features may be described above as working in certain combinations, and even initially claimed as such, in some cases, one or more features in the claimed combination may be removed from the combination, and the claimed combination may be directed to a sub-combination or a variant of the sub-combination.

[0142] Similarly, although operations are depicted in a particular order in the drawings, this should not be understood as requiring that the operations be performed in the particular order shown or in a sequential order, or that all of the illustrated operations be performed to achieve the desired results. Furthermore, the separation of various system components in the embodiments described in this patent document should not be understood as requiring such separation in all embodiments.

[0143] Only a few implementations and examples are described, and other implementations, enhancements, and variations can be made based on what is described and illustrated in this patent document.

Claims

1. A sensor device comprising: substrate; a plurality of first electrodes and a plurality of second electrodes formed on the substrate; a first current collector formed on the substrate and connected to the plurality of first electrodes at one end of each first electrode; as well as a second current collector formed on the substrate and connected to the plurality of second electrodes at one end of each second electrode, The first electrodes and the second electrodes are arranged alternately, and adjacent first electrodes and second electrodes are spaced a predetermined distance apart from each other. 2 . The sensor device of claim 1 , wherein the plurality of first electrodes comprise working electrodes and the plurality of second electrodes comprise reference electrodes or counter electrodes. 3 . The sensor device of claim 1 , wherein the plurality of first and second electrodes comprise at least one of a metal, a carbonaceous material, a doped conductive metal oxide, a conductive polymer, or a metal salt.

4. The sensor device of claim 3, wherein the metal comprises at least one of silver, gold, platinum, copper, titanium, or brass. 5 . The sensor device of claim 3 , wherein the carbonaceous material comprises at least one of graphite, carbon nanotubes, graphene, laser-induced graphene, glassy carbon, or reduced graphene oxide.

6. The sensor device of claim 3, wherein the doped conductive metal oxide comprises indium tin oxide (ITO).

7. The sensor device of claim 3, wherein the conductive polymer comprises at least one of polyaniline, polypyrrole, polythiophene, or poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS).

8. The sensor device of claim 3, wherein the metal salt comprises silver chloride.

9. The sensor device of claim 3, wherein the plurality of first and second electrodes comprise an electroactive redox mediator comprising at least one of a quinone, Prussian blue, an osmium-containing redox mediator, a ruthenium-containing mediator, an organic dye, tetrathiafulvalene, tetrathiafulvalene-tetracyanoquinodimethane, or ferrocene.

10. The sensor device of claim 9, wherein the quinone comprises at least one of benzoquinone, naphthoquinone (NQ), anthraquinone, hydroquinone, or chlorohydroquinone.

11. The sensor device of claim 9, wherein the osmium-containing redox mediator comprises osmium bipyridine.

12. The sensor device of claim 9, wherein the ruthenium-containing medium comprises ruthenium bipyridine.

13. The sensor device of claim 9, wherein the organic dye comprises at least one of methylene blue, toluidine blue O, methylene green, azure A and B, or thionine.

14. The sensor device of claim 1, wherein the substrate comprises a polymer substrate, and wherein the plurality of first and second electrodes comprises one or more solid state interleaved electrodes (IDE) deposited on the polymer substrate.

15. The sensor device of claim 1, wherein the substrate comprises at least one of glass, silicon, paper, textile, polymeric plastic, or elastomer.

16. The sensor device of claim 15, wherein the substrate comprises the polymeric plastic or the elastomer and comprises one or more polymer layers, wherein the one or more polymer layers comprise at least one of the following: polyethylene, polypropylene, polyethylene terephthalate, polyvinyl chloride, polystyrene, a polysaccharide-based polymer, a polystyrene-based block copolymer, a polysaccharide, polyvinyl alcohol, or polyethylene vinyl acetate. 17 . The sensor device of claim 16 , wherein the polystyrene-based block copolymer comprises at least one of polystyrene-polyethylene-polybutylene-polystyrene (SEBS), polystyrene-polyisoprene-polystyrene (SIS), or polystyrene-polybutylene-polystyrene (SBS).

18. The sensor device of claim 16, wherein the polysaccharide comprises at least one of starch polymer, cellulose, nitrocellulose, chitosan, ethyl cellulose, or methyl cellulose.

19. The sensor device of claim 1, wherein the substrate comprises at least one of a fluorinated polymer, a copolymer of the fluorinated polymer, poly(vinyl difluoroethylene), tetrafluoropropylene, or hexafluoropropylene.

20. The sensor device of claim 19, wherein the copolymer of fluorinated polymer comprises poly(tetrafluoroethylene).

21. The sensor device of claim 1, wherein the sensor device is configured to be placed directly on a skin surface to directly interact with natural sweat without the need for a biofluid collection mechanism including microfluidics or hydrogels.

22. The sensor device of claim 21, wherein the biological fluid comprises fingertip sweat.

23. A sensor device according to claim 1, wherein the predetermined distance between the adjacent first and second electrodes includes an ion path for signal transduction when in contact with the user's skin surface through natural perspiration, and wherein the ion path is only established when in contact with the skin and is eliminated when the sensor is removed from the skin surface.

24. The sensor device of claim 1, wherein the predetermined distance is less than 1 mm.

25. The sensor device of claim 1, wherein the plurality of first electrodes and the plurality of second electrodes are interleaved with each other, and wherein the interleaved electrodes are arranged in parallel, radially, or concentrically.

26. The sensor device according to claim 1, further comprising at least one of an enzymatic transduction layer or a non-enzymatic transduction layer formed on the first and second electrodes and the first and second current collectors to selectively react with a biomarker in a body fluid for detection.

27. The sensor device of claim 26, wherein the enzymatic transduction layer comprises an enzymatic material comprising at least one of: glucose oxidase, glucose dehydrogenase, lactate oxidase, lactate dehydrogenase, alcohol oxidase, alcohol dehydrogenase, tyrosinase, ascorbate oxidase, urease, uricase, xanthine oxidase, tyrosinase, glutamate oxidase, laccase, hydroxybutyrate dehydrogenase, catalase, or bilirubin oxidase.

28. The sensor device of claim 26, wherein the non-enzymatic transduction layer comprises an electroactive non-enzymatic material comprising at least one of metal nanoparticles, metals, nanozymes, or ion-selective materials.

29. The sensor device of claim 28, wherein the metal nanoparticles include at least one of gold nanoparticles, platinum nanoparticles, or silver nanoparticles.

30. The sensor device of claim 28, wherein the metal comprises at least one of copper or nickel.

31. The sensor device of claim 28, wherein the ion selective material comprises at least one of a hydrogen ionophore, a sodium ionophore, and a potassium ionophore.

32. The sensor device of claim 26, wherein at least one of the enzymatic transduction layer or the non-enzymatic transduction layer comprises at least one of an enzyme cofactor or a cross-linking chemical deposited below, together with, or on top of at least one of the enzymatic transduction layer or the non-enzymatic transduction layer.

33. The sensor device of claim 32, wherein the enzyme cofactor comprises at least one of nicotinamide adenine dinucleotide, flavin adenine dinucleotide, flavin mononucleotide, heme, or ascorbic acid.

34. The sensor device of claim 32, wherein the crosslinking chemical comprises at least one of glutaraldehyde, epoxy resin, dihydrazide, bisacrylamide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide / N-hydroxysuccinimide (EDC / NHS), a stabilizer, a polymer, or a surfactant.

35. The sensor device of claim 34, wherein the stabilizer comprises at least one of bovine serum albumin, human serum albumin, glycerol, or polyphenylene diamine.

36. The sensor device of claim 34, wherein the polymer comprises at least one of polyethyleneimine, polyurethane, polyvinyl alcohol, polyvinyl pyrrolidone, chitosan, or Nafion.

37. The sensor device of claim 34, wherein the surfactant comprises at least one of sodium dodecyl sulfate, sodium dodecylstyrene sulfonate, Triton X-100, Triton X-114, or Tween 80.

38. The sensor device of claim 1, further comprising: a signal transduction layer disposed on the first electrode and the second electrode to functionalize the first electrode and the second electrode for a biomarker; as well as The protective layer on the signal transduction layer is used to protect the signal transduction layer.

39. The sensor device of claim 38, wherein the protective layer comprises at least one of: Nafion, chitosan, polyethyleneimine, polyurethane, polyvinyl alcohol, polyvinyl chloride, poly(vinyl difluoride), poly(tetrafluoroethylene), tetrafluoropropylene, hexafluoropropylene, starch polymer, cellulose, nitrocellulose, chitosan, ethyl cellulose, or methyl cellulose.

40. The sensor device of claim 1, wherein the sensor device is configured to selectively react with biomarkers in a body fluid for detection, wherein the biomarkers include at least one of glucose, lactate, alcohol, levodopa, creatinine, urea, uric acid, bilirubin, hydroxybutyrate, vitamins, oxygen, ions, hormones, opioids, or cannabinoids.

41. The sensor device of claim 40, wherein the vitamin comprises ascorbic acid.

42. The sensor device of claim 40, wherein the ions include at least one of protons, sodium, potassium, chloride, fluoride, calcium, zinc, lead, cadmium, or mercury.

43. The sensor device of claim 40, wherein the hormone comprises at least one of Cortisol, adrenaline, or insulin.

44. The sensor device of claim 1, wherein the sensor device is integrated with an additional sensor for measuring a physical parameter when in contact with the skin, wherein the physical parameter comprises at least one of temperature, humidity or pressure.

45. The sensor device of claim 1, wherein the sensor device is integrated with additional sensors for measuring physiological parameters when in contact with the skin, wherein the physiological parameters include skin resistance, temperature, blood oxygen level, heart rate, fingerprint pattern or blood pressure.

46. ​​A sensor device comprising a plurality of electrode arrays for simultaneously or sequentially sensing a plurality of biomarkers of a physiological parameter, wherein each of said electrode arrays comprises: a plurality of first electrodes and a plurality of second electrodes; a first current collector connected to the plurality of first electrodes at one end of each first electrode; as well as a second current collector connected to the plurality of second electrodes at one end of each second electrode, The first electrodes and the second electrodes are arranged alternately, and adjacent first electrodes and second electrodes are spaced a predetermined distance apart from each other.

47. A sensor array comprising a plurality of sensor devices according to any one of claims 1 to 46, wherein the plurality of sensor devices are formed on a substrate for simultaneously or sequentially sensing a plurality of biomarkers in a biological fluid from different locations of the body.

48. A method comprising: placing the sensor device of any one of claims 1 to 47 in contact with the skin of a subject; as well as The biomarker is measured in a biological fluid from the subject's skin using the sensor device.

49. The method of claim 48, wherein the biomarker comprises at least one of glucose, lactate, alcohol, levodopa, creatinine, urea, uric acid, bilirubin, hydroxybutyrate, vitamins, oxygen, ions, hormones, opioids, or cannabinoids.

50. The method of claim 48, further comprising measuring at least one of a physical parameter or a physiological parameter along with the biomarker, The physical parameter includes at least one of temperature, humidity or pressure, and the physiological parameter includes at least one of skin resistance, temperature, blood oxygen level, heart rate, fingerprint pattern or blood pressure.

Citation Information

Cited By

  • Nanoprobe integrating in-situ internal reference, administration and fixed-point recording and preparation method thereof

    CN119710576A

  • Flexible pressure sensor and preparation method thereof, and wearable device

    CN120820262A

  • Flexible pressure sensors and their fabrication methods, wearable devices

    CN120820262B

  • Implantable flexible microneedle sensor for continuously monitoring glucose and uric acid

    CN121943302A

  • Gingival crevicular fluid multi-marker detection electrochemical sensor based on size layering and difference configuration as well as preparation and detection methods of gingival crevicular fluid multi-marker detection electrochemical sensor

    CN122567991A